-
ONX-0914 (PR-957) Experimental Workflows
2026-09-10
ONX-0914 (PR-957) provides selective LMP7 inhibition for separating immunoproteasome biology from constitutive proteasome effects. This practical guide connects cytokine assays, autoimmune disease models, and a reference-informed hippocampal workflow with formulation, dosing, and troubleshooting strategies.
-
SU5416 (Semaxanib) for Vascular Remodeling Studies
2026-09-09
SU5416 (Semaxanib) enables controlled VEGFR2 blockade across endothelial, tumor, and vascular-remodeling models. This guide connects practical angiogenesis workflows with subject-specific pulmonary hemodynamics, while addressing dosing, solvent handling, assay selection, and interpretation limits.
-
Wnt agonist 1: Applied Research Workflows
2026-09-09
Wnt agonist 1 (BML-284) provides a controllable small-molecule approach for canonical Wnt signaling pathway activation, from differentiation assays to developmental models. This guide translates the Wnt/NR2F2/GPX4 chemoresistance findings into practical experimental designs while separating validated evidence from testable extensions.
-
Z-VAD-FMK Workflows for Apoptosis Research
2026-09-08
Use Z-VAD-FMK to distinguish caspase-dependent apoptosis from persistent cell death, while preserving orthogonal readouts for inflammasome signaling and pyroptotic outcomes. This workflow combines disciplined stock handling, time-resolved caspase activity measurement, and structural insight from full-length ASC research.
-
Luminescent ATP Cell Viability Assay Kit I: Ferroptosis
2026-09-08
Learn how the Luminescent ATP Cell Viability Assay Kit I converts ATP abundance into a rapid, sensitive viability endpoint for ciprofloxacin–RSL3 ferroptosis studies. This guide focuses on experimental interpretation, assay design, and the limits of ATP-based conclusions.
-
Cepharanthine: From Phenotype to Mechanism
2026-09-07
Cepharanthine is a biscoclaurine alkaloid with a distinctive evidence profile spanning endometriosis cells, patient-derived organoids, and animal lesions. This guide explains how to convert its apoptosis and DNA-damage signals into better assay decisions without overstating preclinical or clinical evidence.
-
NSP15 Screening Identifies Thymopentin and Oleuropein
2026-09-05
The 2021 reference study used structure-based virtual screening and molecular dynamics to prioritize thymopentin and oleuropein as candidate inhibitors of SARS-CoV-2 NSP15. Its main practical contribution is a computational workflow for ranking natural products against a viral immune-evasion factor, while its predictions still require biochemical, cellular, and in vivo validation.
-
Golgi-Tracker Green: Live-Cell Golgi Workflow
2026-09-05
Golgi-Tracker Green is a photostable BODIPY FL-labeled C5-ceramide probe for selective Golgi visualization in living cells. This guide connects live-cell Golgi imaging with lipid-transport assays, sphingolipid metabolism analysis, and quantitative studies of Golgi remodeling.
-
Tiamulin (Thiamutilin): Applied Research Workflows
2026-09-04
Tiamulin combines pleuromutilin antibacterial activity with experimentally supported anti-inflammatory effects, creating a useful bridge between veterinary infection models and cytokine-driven cell assays. This workflow-focused guide covers preparation, pathway readouts, antimicrobial testing, formulation controls, and troubleshooting.
-
MEHP, AhR, and Ovarian Follicle Toxicity
2026-09-04
A 2024 Biology of Reproduction study shows that mono(2-ethylhexyl) phthalate disrupts mouse antral follicle growth and estrogen-related signaling partly through aryl hydrocarbon receptor activation. Pharmacological blockade with CH 223191 linked AhR activity to Cyp1a1 and Cyp1b1 induction, reduced estrogen production, and altered ovarian gene expression, providing a mechanistic framework for endocrine-disruptor research.
-
4-MUG for Lysosomal Enzyme Activity Assays
2026-09-03
4-Methylumbelliferyl-β-D-Glucopyranoside enables sensitive, flexible measurements of β-glucosidase and β-glucocerebrosidase activity in lysosomal disease models. This practical guide connects assay design with recent GBA1 mRNA research, emphasizing controls, pH matching, kinetic linearity, and troubleshooting.
-
Ciprofloxacin Hydrochloride: Applied Lab Workflows
2026-09-03
Ciprofloxacin hydrochloride supports reproducible antibacterial assays while offering a disciplined way to investigate immunomodulatory and emerging anti-parasitic questions. This guide connects DNA replication inhibition, host-cell viability testing, and the quinolone-derived Toxoplasma study to practical workflows and troubleshooting decisions.
-
Dhcr7 Knockout Grass Carp Resists GCRV
2026-09-02
A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and demonstrated substantially improved resistance to lethal GCRV-II infection. The work connects Dhcr7-dependent sterol metabolism with IRF3-associated antiviral immunity while preserving measured growth and muscle traits, providing an in vivo target for disease-resistant aquaculture breeding.
-
NF 449: A Precision P2X1 Research Workflow
2026-09-02
NF 449 combines subnanomolar P2X1 antagonism with a workflow that links recombinant ion-channel pharmacology to platelet biology. Use it to separate ATP-gated signaling from broader purinergic effects in platelet activation, collagen responses, and antithrombotic agent research.
-
PF-573228 FAK Inhibitor Workflow
2026-09-01
PF-573228 helps separate stiffness-driven signaling from downstream differentiation, migration, survival, and angiogenesis phenotypes. This practical workflow connects odontoblast mechanobiology with cancer and endothelial assays while emphasizing target engagement, dose selection, and troubleshooting.